Archive · 10 Nov 2025
Indian Study Suggests Collagen May Worsen Type 2 Diabetes
Imagine your body's cells have a little neighborhood called the pancreas, which makes insulin to help your body use sugar.
In Type 2 diabetes, this neighborhood doesn't work as well.
Scientists found that a building material in this neighborhood, called collagen, might be making things worse.
Collagen helps build things, but it seems it might also help sticky blobs called amylin stick together.
These sticky blobs can hurt the cells that make insulin.
The study, done in India where lots of people have diabetes, saw that both collagen and amylin went up as diabetes got worse.
They even saw that when insulin-making cells were grown on collagen, they got more stressed.
This means that when we think about diabetes, we might need to consider this building material, collagen, and not just the insulin itself.
It's still early research, so it doesn't mean you should stop using collagen products, but it's something doctors should know about, especially for patients not getting better with regular treatments.
More research is needed to see if changing collagen could become a new way to help treat diabetes.
A study from IIT Bombay suggests collagen I may accelerate amylin aggregation in pancreatic tissue, contributing to Type 2 diabetes progression.
The findings highlight the role of the extracellular matrix, specifically collagen, in beta-cell damage beyond traditional metabolic understandings.
Human and mouse data showed collagen I and amylin levels rise in tandem with diabetes progression in islet tissue.
The study indicates that while pre-clinical, it raises questions about the impact of popular collagen supplements on pancreatic health in diabetic patients.
Further research is needed to move from mechanistic insight to clinical therapies targeting collagen for Type 2 diabetes treatment.
- Who
- Researchers at IIT Bombay
- What
- Discovered that the structural protein collagen I may accelerate amylin aggregation in pancreatic tissue, contributing to beta-cell damage and potentially worsening Type 2 diabetes.
- When
- Recently published findings
- Where
- India (IIT Bombay)
- Why
- To understand the progression of Type 2 diabetes beyond traditional models focusing on insulin resistance and beta-cell dysfunction.
Potential Role of Collagen in Diabetes Progression
Need for More Research and Caution
Collagen's Impact on Pancreatic Health
Potential Role of Collagen in Diabetes Progression
Collagen I may act as a scaffold accelerating amylin aggregation in pancreatic tissue, leading to beta-cell damage and worsening Type 2 diabetes.
Need for More Research and Caution
The study is pre-clinical and does not establish that collagen supplements worsen diabetes in humans or provide direct clinical trial evidence that targeting collagen I will reverse diabetes.
Therapeutic Implications
Potential Role of Collagen in Diabetes Progression
The findings suggest a need to consider extracellular matrix therapies or interventions that modify the islet-microenvironment, potentially opening new treatment horizons beyond current metabolic approaches.
Need for More Research and Caution
Current mainstream diabetes management relies on lifestyle control and appropriate medication; future therapies targeting collagen are not yet established.
Collagen Supplements
Potential Role of Collagen in Diabetes Progression
The impact of popular collagen supplements on the pancreas in diabetes may warrant caution, as their role is unconstrained and has not been directly tested in this context.
Need for More Research and Caution
Patients should continue evidence-based lifestyle habits and consult an endocrinologist before using collagen supplements, as long-term implications in diabetes are unstudied.
- Disease
- Type 2 Diabetes
- Key Protein Implicated
- Collagen I
- Mechanism Suggestion
- Collagen I accelerates amylin aggregation in pancreatic islet tissue, damaging beta-cells.
- Study Origin
- IIT Bombay
- Publication
- Journal of the American Chemical Society (JACS)
- Implicated Component
- Extracellular matrix (ECM)
- Human Diabetes Burden (India)
- Estimated over 100 million adults